Advanced Stage and Relapsed/Refractory Hodgkin Lymphoma
Author and Disclosure Information [Show]

Ravi Kishore Narra, MD
Assistant Professor of Medicine Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Jasleen Randhawa, MD
Houston Methodist Cancer Center, Houston, TX

Timothy S. Fenske, MD
Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

Question 1 of 5

A 47-year-old man presents with high fevers and weight loss for 2 months. On examination, he is found to have cervical, supraclavicular, axillary, and inguinal lymphadenopathy. Laboratory work-up shows a hemoglobin level of 11.5 g/dL, white blood cell (WBC) count of 16,000 cells/μL, and a serum albumin level of 3.3 g/dL. Excisional biopsy of an inguinal lymph node is consistent with classical Hodgkin lymphoma (cHL).

Which one of the following factors pertaining to this patient is not an adverse prognostic marker?

Age of 47 years

Albumin level of 3.3 g/dL

Hemoglobin of 11.5 g/dL

WBC count of 16,000 cell/μL

None of the above

Hospital Physician: Hematology/Oncology. 2017 September;12(5)

This quiz is not accredited for CME.

More from Board Review Questions: Hematology/Oncology


Autoimmune Hemolytic Anemia
Gastrointestinal Stromal Tumors
Testicular Cancer
Management of Advanced Melanoma
Castration-Resistant Prostate Cancer
Transfusion Reactions (part 2)
Transfusion Reactions (part 1)
Plasma Cell Disorders (part 3)
Plasma Cell Disorders (part 2)
Chronic Myeloid Leukemia
Aplastic Anemia
Management of Metastatic Gastric Cancer
Transfusion Medicine
Small Cell Lung Cancer
Management of Colorectal Cancer in Older Adults
Urothelial Carcinoma: Muscle-Invasive and Metastatic Disease
Acute Myeloid Leukemia
Pancreatic Adenocarcinoma: Advanced Unresectable and Metastatic Disease
HER2-Positive Breast Cancer
Aggressive B-Cell Non-Hodgkin Lymphoma
Von Willebrand Disease: Clinical Management
Von Willebrand Disease: Assessment and Diagnostic Testing
Pancreatic Adenocarcinoma: Neoadjuvant and Adjuvant Treatment
Late Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Polycythemia Vera and Essential Thrombocythemia: Current Management
Treatment of Biliary Tract Cancers
Early Pulmonary Complications After Hematopoietic Stem Cell Transplantation
Hairy Cell Leukemia
Genomic Testing in Women with Early-Stage Hormone Receptor–Positive, HER2-Negative Breast Cancer
Immune Thrombocytopenia
Cancer-Related Fatigue
Disseminated Intravascular Coagulation
Adjuvant Chemotherapy for Colon Cancer
Molecular Markers and Targeted Therapies in the Management of Non-Small Cell Lung Cancer
Metastatic Cutaneous Melanoma: Targeted Therapy and Immunotherapy
Thrombosis in Pregnancy
Locally Advanced Pancreatic Cancer
Early-Stage Hodgkin Lymphoma
Neoadjuvant and Adjuvant Therapy for Gastric Cancer
Hemophilia A and B
Mantle Cell Lymphoma
Soft Tissue Sarcoma
Sickle Cell Disease
Renal Cell Carcinoma
Management of Locally Advanced Rectal Adenocarcinoma
Adjuvant Systemic Therapy for Early-Stage Breast Cancer
Chronic Myeloid Leukemia
Plasma Cell Disorders
Myelodysplastic Syndromes
Acute and Chronic Graft-versus-Host Disease